"That's Terrible!" | What Statin Trials Really Show

For more nuances, references and a written breakdown, join the StayCurious Metabolism newsletter: https://staycuriousmetabolism.substack.com/p/the-ldl-illusion-what-statin-trials?r=40ekz2 Statins and Mitochondrial Health: https://youtu.be/qHXMI3DudEc Breaking Statins (with a Hammer): https://youtu.be/cX7qzj4qazg Description: What if the number your doctor focuses on most isn’t actually predicting what matters? LDL cholesterol has become the central metric in cardiovascular medicine because it’s easy to measure and easy to change, and easy to standardize. But large-scale analyses suggest that reductions in LDL cholesterol may be a surprisingly weak predictor of real cardiovascular outcomes. In this video, I break down a major umbrella review published in the European Heart Journal covering nearly 200,000 patients across 20 randomized controlled trials. The core question is simple but uncomfortable: does lowering LDL cholesterol reliably predict fewer heart attacks, strokes, or deaths? The answer, based on the data, is not what most people expect. We also look at replication data from JAMA Internal Medicine, explore why statins may still help certain patients despite LDL being a poor surrogate marker, and explain the concept of pleiotropy—how drugs can work through multiple biological pathways unrelated to cholesterol. Chapter: 0:00 – Why LDL Cholesterol Can Be Misleading (The Hot Chocolate Analogy) 1:37 – New Meta-Analysis: 20 Randomized Controlled Trials Reviewed 3:17 – Why LDL Reductions Failed to Predict Heart Outcomes 4:37 – Replication Matters: Independent Trials Show the Same Pattern 5:54 – One Pill, Many Effects: How Statins Work Beyond LDL 9:45 – Final Takeaway: Why Surrogate Markers Can Mislead in Medicine #LDL #Cholesterol #HeartDisease #Statins #CardiovascularHealth #MetabolicHealth #Inflammation #ApoB #PrecisionMedicine #EvidenceBasedMedicine #HealthScience #MedicalEducation #StayCurious